Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM

Blaser, Nello; Bertisch, Barbara; Kouyos, Roger D.; Calmy, Alexandra; Bucher, Heiner C.; Cavassini, Matthias; Estill, Janne Anton Markus; Keiser, Olivia; Egger, Matthias

doi:10.1097/QAD.0000000000001546

Scientific article

English

Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM

ContributorsBlaser, Nello; Bertisch, Barbara; Kouyos, Roger D.; Calmy, Alexandra

; Bucher, Heiner C.; Cavassini, Matthias; Estill, Janne Anton Markus; Keiser, Olivia

; Egger, Matthias

Published inAIDS, vol. 31, no. 13, p. 1859-1866

Publication date2017

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires / Institut de santé globale

Research groups

Citation (ISO format)

BLASER, Nello et al. Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM. In: AIDS, 2017, vol. 31, n° 13, p. 1859–1866. doi: 10.1097/QAD.0000000000001546

Article (Accepted version)

Identifiers

PID : unige:100021
DOI : 10.1097/QAD.0000000000001546

Additional URL for this publicationhttp://Insights.ovid.com/crossref?an=00002030-201708240-00011

Journal ISSN0269-9370

595views

450downloads

Creation01/11/2017 15:52:00

First validation01/11/2017 15:52:00

Update15/03/2023 07:32:55

Status update15/03/2023 07:32:54

Last indexation31/10/2024 08:56:56

Archive ouverte UNIGE

Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM

Technical informations